Technological Advancements Spur Auto-Injectors Industry

13 October 2020: Auto-injector is a medical device used to deliver a single, fixed dose of critical drug. They are an effective mode of management for intramuscular drugs. The user-friendly nature of auto-injectors decreases the burden of carrying conventional syringes and needles. They are easy to use and are used for self-administration by patients or can also be administrated by untrained personnel. 

                                                               Auto-Injectors Market

Anaphylaxis’s Sector Holds Largest Share in the Market

On the basis of disease indication type, the auto-injectors market is classified into multiple sclerosis, rheumatoid arthritis, anaphylaxis, diabetes, and other therapies. The anaphylaxis sector accounted for the largest share in 2018 owing to increasing occurrence of anaphylactic reactions on account of medications, food, insect stings, and latex. 

According to the Asthma and Allergy Foundation of America, allergic conditions are the most common health problems affecting children in the U.S. In 2015, 4.2 million kids suffered from food allergies and 8.8 million suffered from skin allergies in the U.S. In Europe, allergies are one of the most common chronic diseases with nearly 20% of these patients fear of probable asthma attack, anaphylactic shock, and even death from these reactions. 

Market Insights

Key parameter in the growing competition is rapid adoption of advanced devices for improved healthcare. Leading players in the market are frequently opting for mergers and acquisitions along with novel product introductions to hold their share and expand the product range.

As per the Centers for Disease Control and Prevention (CDC), around 54.4 million adults were identified with numerous types of arthritis such as, lupus, gout, fibromyalgia, and rheumatoid arthritis in U.S. during 2013-2015. 

Recently, Biogen Idec, Inc. received the Food and Drug Administration (FDA) approval for its novel drug Plegridy used for the treatment of multiple sclerosis. The firm has improved the drug by adding polymer termed PEG (polyethylene glycol) that increases the drug exposure in patients and decreases the frequency of drugs administration. 

Some of the key players effective in the auto-injectors market are Scandinavian Health Ltd.; Eli Lilly; AbbVie, Inc.; Owen Mumford; Amgen; Ypsomed; Biogen Idec; Teva Pharmaceutical; Mylan N.V.; Sanofi; and Pfizer, Inc.

Cardiovascular Ultrasound (CVUS) Provides Enhanced Diagnosis of Heart Diseases

14th May 2020: The cardiovascular ultrasound (CVUS) market is likely to witness growth due to increasing prevalence of cardiovascular disease and rise in penetration of preventive medicine across the globe. Cardiology is a study that involves structures of heart and their functions in medicine. Major function of heart is blood circulation and carrying oxygen through blood. Noninvasive ultrasound technology is used by cardiologists, vascular surgeons, and internal medicine providers for imaging to diagnose and analyze function of the heart. 

Echocardiography Enables Detection of Heart Abnormalities before Birth  

Based on type, the market is segmented into transesophageal echocardiography, transthoracic echocardiography, and fetal echocardiography. The fetal echocardiography segment is likely to witness the fastest growth over the forecast period. 

In order to check all the four chambers of the heart and to track the development, fetal echocardiogram is used in the second trimester of the pregnancy tests. It enables visualization of the structure of the heart of the unborn child. Fetal health monitoring and increased awareness regarding the same has resulted in the surge in demand for cardiovascular ultrasound.

Transesophageal echocardiography is used when other procedures are unable to provide results. Increase in incidences of cardiovascular diseases (CVDs), technological advancements, and advantages of echocardiography over other imaging technologies are the factors responsible for growth of the segment. Cardiovascular ultrasound is highly noninvasive, reducing the duration of hospital stay, which is further fueling the growth of the market. 

Market Insights

The growth of the cardiovascular ultrasound industry is due to the benefits provided by the technology such as rapid results and quality images of heart conditions. Increasing R&D activities, rising investment in healthcare and meditech industry, and high prevalence of cardiovascular diseases are the key factors driving growth of the cardiovascular ultrasound industry. Technological advancements in heart related conditions such as lateral gain control, tissue enhancements, tissue Doppler, advanced dynamic flow, and stress echo provides varied growth opportunities for the market players. 

Major companies of the cardiovascular ultrasound industry such as Philips Healthcare and Siemens Healthcare have B/W devices, which help to shift to the color mode of the ultrasound imaging to provide clarity and better diagnostic. For instance, Hitachi provides these color systems that are available in many countries around the world. 

Some of the leading companies of the cardiovascular ultrasound market include Siemens Healthcare; GE Healthcare, Inc.; Hitachi; Philips; Canon Medical Systems Corporation; and Fujifilm Medical Systems.

Healthcare Staffing- An Emerging Field in Nursing Facilities

23 April 2020: Healthcare staffing refers to services person, corporation, firm, partnership, or a business involved in referring or providing nursing workers to a health care agency, a facility, or an individual to render short-term nursing facilities.

Allied Healthcare Segment to Contribute Substantial Demand to the Market

The major service type variants in the market include allied healthcare, per diem nurse, travel nurse, and locum tenens. The allied healthcare type sector accounted for the largest share in the market and will continue its dominance over the forthcoming period. On the other hand, locum tenens segment is anticipated to register the fastest CAGR in the forecast period. 

Allied healthcare includes respiratory therapists, physical therapists, medical technologists, phlebotomists, occupational therapists, and pharmacists. Lack of professionals in established economies, growing demand owing to rising aged population, and unhealthy lifestyle are likely to drive the segment growth in the forecast period.  

The Indian government revised the bill for regulating allied healthcare services in January 2017 and is anticipated to bring it under the range of a national regulator. The Union Health Ministry of India revised the Allied and Healthcare Council Bill in order to monitor more than 50 categories of healthcare and allied professionals and standardize their practices and education. This will affect more than 40% of the total healthcare specialists and is expected to surge their shortage in India.

The factors responsible for the growth of sector include preference of physicians to work as cost-efficient and locum tenens for employers. As per the investigation by Staff Care, an AMN Healthcare firm, it was detected that the total number of physicians operating as locum tenens is constantly rising. 

Market insights:

Mergers and acquisitions to expand the service portfolio and geographical reach are the significant policies being accepted by key players to upsurge their market share. 

For example, in June 2016, AmSurg Corporation and Envision care Holdings, Inc., signed a contract and formed Envision care Corporation. This merger is poised to progress the market share of both the corporations.

Leading players operating in the healthcare staffing market include Almost Family; Adecco Group; AMN Healthcare; Cross Country Healthcare, Inc.; CHG Management, Inc.; inVentiv Health; Envision Healthcare Corporation; TeamHealth; and Maxim Healthcare Services, Inc. 

Regenerative Medicine by Amniotic Membrane to Offer Treatment for Several Diseases

2 April 2020: The amniotic membrane market is likely to witness growth due to demand for its applications in surgical graft, management of wounds, and biological bandage for the treatment. It is the innermost layer of placenta and is used for wound healing and contains bacteriostatic and pain reduction properties. Amniotic membranes are used for reconstruction of the conjunctiva surface, surgical wounds, excisions, venous and pressure leg ulcers, and regenerative medicine. Factors fueling the growth of the market are rise in the number of surgeries being performed and R&D investments in the field of stem cell and regenerative medicine.

Ambulatory Surgical Centers (ASCs) Promote Quick Patient Recovery 

On the basis of end use, the market is segmented into Ambulatory Surgical Centers (ASCs), hospitals, research, specialty clinics, and academic institutes. Hospitals offer treatment for a wide range of diseases and accounts for the largest market share. Frequent visits by patients and facilities of surgical interventions are the factors responsible for the growth of this segment.

Increasing usage of amniotic membranes in ASCs is due to its effective wound recovery properties and reduced visits to hospitals. Hence, ASC segment is anticipated to achieve a rapid growth over the next few years. Amniotic membrane is used in specialty clinics such as plastic surgery clinics, burn centers, dermatology clinics, and others require methods to prevent infections and promote effective wound healing thus facilitating market growth. Amniotic membrane also promotes stem cells and regenerative medicine propelling growth of the market.

Market Insights

High demand for the product due to its applications in cosmetic surgeries is boosting the market growth. It is used in reconstructive procedures, which is another reason for its high demand. It has other benefits such as reduced fibrosis and anti-inflammatory properties that have advantages in medical treatments thus fueling the demand. Research and academic institutes are also witnessing growth due to high R&D investments by leading companies and hospitals. 

Some of the major companies of the amniotic membrane market are Amnio Technology, LLC; Alliqua BioMedical, Inc.; Human Regenerative Technologies, LLC; Applied Biologics LLC; MiMedx Group, Inc.; DermaSciences; Katena Products, Inc.; Amniox Medical, Inc.; Skye Biologics, Inc.; and Organogensis, Inc.

High demand of Manual Resuscitators in COPD to Boost Its Demand

31st March 2020: Manual resuscitator is a breathing apparatus that offers positive pressure ventilation to the lungs of the patient and keeps them alive or oxygenated in case of respiratory arrest. Manual resuscitators is further termed as Artificial Manual Breathing Unit (AMBU) bag or Big Valve Mask (BVM). An easy manual AMBU resuscitator is a convenient and handheld ventilator comprising of three parts, namely a valve, a mask, and a bag.  

Hospitals Segment to Contribute Substantial Demand for Manual Resuscitators 

Hospitals sector accounted for the largest share in the manual resuscitators market and is anticipated to expand at the fastest CAGR in the forthcoming period. Bag valve masks (BVMs) in hospitals are mainly used in cases of intensive care, neonatal care, and cardiac arrest. 

The American Health Association (AHA) made available the first guideline for researching, reporting, and reviewing in-hospital resuscitation. In-hospital as a mechanism of international standardizations the Utstein Style was published and is used as a reporting system for patient monitoring.

For example, the AHA has started the National Registry of Cardiopulmonary Resuscitation (NRCPR), which perform as a multi-site information gathering source. The registry allows inter-facility comparison among numerous hospitals, starting a standardized mechanism.

In addition, the use of outside hospital resuscitators is anticipated to observe a faster development on account of growing need to offer bystander cardiopulmonary resuscitation and the associated consciousness initiatives taken. 

Market Insights: 

The key companies such as Laerdal offer resuscitation training material and workshops to improve the consciousness towards cardiac resuscitation. In January 2016, Laerdal Medical and SonoSim, Inc. worked in partnership to introduce the ultrasound solution for SimMan and SimMom. 

The solution offers classroom learning associated with critical care, pregnancy, and trauma care.  Furthermore, companies are following mergers and acquisitions to increase their global presence in these manual resuscitators. 

Leading players operating in the manual resuscitators market include Laerdal Medical; Weinmann Emergency; HUM Systems for Life; Ambu A/S; Me. Ber. srl; Medline Industries; Hopkins Medical Product; Philips Healthcare; Covidien Plc; Drager Medical AG and Co.; ResMed, Inc.; CareFusion; and GE Healthcare.

Increasing Occurrences of Chronic Diseases is Boost the Enteral Feeding Devices

19th Dec 2019: Enteral feeding devices are medical devices that help deliver medications and nutrients directly in the intestine or stomach under supervised condition. Enteral feeding devices are mainly used to feed a particular diet to bedridden or elderly patients suffering from chronic illnesses, such as cancer, neurological disorders, inherited metabolic diseases, and gastrointestinal diseases. 

Oncology Sector to Boost Overall Market Growth

The major application variants of the enteral feeding devices market include neurology, oncology, critical care, and diabetes. The oncology sector accounted for the largest share in the market and is anticipated to expand at the fastest CAGR in the forthcoming period. Rising occurrence of head and neck cancer contributes to its fueled revenue share on account of patients facing issues with normal swallowing process. 

As per American Cancer Society, 64,690 people developed neck and head cancer in the U.S. in 2018. Patients with cancer suffer major weight loss and severe malnutrition induced by the tumor or its associated therapy comprising radiations, chemotherapy, and tumor removal surgeries. This requires feeding them through tubes, which will in turn, propel the demand for enteral feeding devices. 

To develop formulas, manufacturers are mainly targeting the cancer-related conditions, thereby increasing the acceptance of enteral feeding formulations in cancer patients. For example, ProSure by Abbott is formulated for cancer patients suffering from unintended weight loss and cachexia. It improves appetite, promotes weight gain, strengthens immune response, and maintains lean muscle mass.

The oncology segment is followed by diabetes segment and is expected to emerge as the fastest growing sector in the enteral feeding devices during the forecast period. Rising need for glucose control in hospitalized patients will propel the demand for diabetes-specific feeds. 

Market Insights: 

The key companies are constantly capitalizing on R&D activities for novel product development that provide niche therapeutic areas with high development potential to increase a competitive edge. Market entry is challenging for new companies as space is dominated by the foremost multinational company (MNCs) with high brand recognition. On the other hand, the enteral feeding devices market presents profitable opportunities for small companies in the Asia Pacific on account of its high development rate.

Leading players operating in the enteral feeding devices market include Abbott Nutrition; CONMED Corporation; Kimberly Clark; Boston Scientific Corporation; Amsino International Inc.; Cook Medical; Danone Medical Nutrition; and Moog Inc.

Technological Progression to Fuel Demand for Anesthesia & Respiratory Devices

12 December 2019: Anesthesia devices support anesthesiologists in precisely managing anesthetic vapors or gases in a desired concentration and quantity. They function as a key instrument during various surgical procedures. Respiratory devices simplify breathing during respiratory failure and other respiratory diseases. They are also used to deliver medication and to relax patients. 

Respiratory Devices Sector to Contribute Substantial Demand to the Market

The respiratory devices sector accounted for the fastest growth in the market and is anticipated to expand at the fastest CAGR in the forthcoming period. Increase in the number of surgeries performed, growing occurrence of respiratory diseases, and rising healthcare spending are the key factors anticipated to drive the sector growth in the forecast period.

Anesthesia devices are further segmented into disposables and machines. The machines sub-segment comprise of delivery machines, monitors and ventilators, and workstations. Anesthesia disposables comprise of accessories and masks. 

The respiratory equipment is classified into nebulizers, oxygen concentrators, respiratory inhalers, ventilators, humidifiers, and positive airway pressure devices. The positive airway pressure devices led the global anesthesia and respiratory devices and is estimated to witness significant development over the forthcoming period. The positive airway pressure devices sector is majorly driven by the rising occurrence of respiratory disorders, such as asthma, tuberculosis, and cystic fibrosis. 

Market Insights: 

The anesthesia and respiratory devices market is highly competitive and the key companies are investing in the growth of advanced and unique devices. Companies are accepting many developmental policies in developing economies such as India and Brazil, through agreements and acquisitions in order to surge their market shares.

In Asia Pacific, Japan accounts for a major market share due to increasing geriatric population. In countries such as India and China, the population suffers pulmonary diseases which will further boost the demand for these devices. COPD is one of the biggest causes of death in India says a study published in International Journal of Pulmonary and Respiratory Sciences. This could further drive the market demand in Asia Pacific region.

Leading players operating in the anesthesia and respiratory devices market include B. Braun Medical Inc.; AirSep Corporation; BD; Medtronic; Getinge AB; Drägerwerk AG & Co. KGaA; GE Healthcare; Smiths Medical; Philips Healthcare; Masimo Corporation; and Teleflex Inc.

Wearable medical device industry offers advanced health monitoring

The wearable medical device market is expected to witness growth over the forecast period due to demand for better healthcare facilities and remote patient monitoring. In addition, rising focus on fitness and healthy living are also expected to fuel the market growth.

High prevalence of lifestyle related disorders along with diabetes and hypertension, occurring due to sedentary lifestyle, requires special attention. It needs continuous observation of various physiological parameters, such as blood pressure and blood sugar levels. This enables immediate information access with portable systems, which can be forwarded to physicians for enhancing treatment with minimal errors. Rising mortality rate due chronic diseases is a major concern as they need intensive care and monitoring. These factors are expected to fuel the product demand in the near future. 

Innovation in medical devices to benefit health care

On basis of product, the market is segmented into therapeutics and diagnostics. Therapeutic is expected to attain the fastest CAGR throughout the forecast period due to high demand of the technology. The segment includes insulin monitoring, pain management, rehabilitation, and respiratory therapy. Therapeutic technology includes intelligent asthma management, insulin management, and wearable pain reliever devices. Insulin monitoring is expected to be the dominant segment over the next few years due to rising prevalence of diabetes. Continuous glucose monitoring systems and wearable insulin delivery systems have transformed diabetes management. 

The wearable medical device industry is now on the verge of transformation as it is witnessing increasing development of medical grade systems. These wearable medical devices are designed to be easily worn and integrated into everyday life by incorporating advanced technology. This has also led to the systems being designed lighter, smaller, and less invasive. 

Market insight

The wearable medical devices industry is expected to witness a high demand due to rapid innovations in the medical sector. These systems are becoming increasingly popular due to their improved technologies and easy use. Key players in the wearable medical device market include Fitbit Inc.; Polar Electro; Philips Electronics; Covidien Plc; LifeWatch AG; Garmin; Withings; Jawbone; Everist Genomics; Sotera Wireless; and Vital Connect.

Minimally Invasive Surgical Instruments to Offer Affordable Surgeries

1 August 2019: The minimally invasive surgical (MIS) instruments are used in minimally invasive surgeries. These surgical procedures are performed to limit the number and size of incisions and cuts to reduce the wound recovery time. In addition, several types of less invasive instruments are used in these surgeries such as catheters, compact cameras, small tubes, etc. that reduce the pain, hospital stay, and also complications.

Advantages of Minimally Invasive Surgeries over Conventional Technique to Boost the Market

On the basis of application, minimally invasive surgical instruments market can be classified into Gastrointestinal, Cardiac, Vascular, Orthopedic, Urological, Gynecological, Thoracic, Dental, Cosmetic, and Others. 

The Orthopedic segment is the largest application segment in the market. In orthopedic MIS methods, no muscles are required to be separated or cut from the bone thus, enhancing the healing process and patient satisfaction. 

Most often, MIS is used in knee as well as hip replacement surgery. Surgeons and hospitals search for operating methods that result in decreased operative as well as postoperative complications and decreased hospitalization period. However, patients seek surgical treatments that reduce trauma and provide quick recovery. 

The orthopedic segment is followed by cosmetic segment and is anticipated to be the fastest growing application sector over the forthcoming period. The factors such as increasing demand for cosmetic surgeries over traditional surgical approach, which is leading to technical development in the field will drive the segment growth in the forecast period.  

Market insights: 

In 2017, Medtronic offered numerous orthopedic MIS solutions for coronary artery disease and was a leader in terms of market presence. Furthermore, the company has established a system for stabilization and spinal surgery based on MIS methods.

Another reputable key player, Intuitive Surgical, Inc., offers the da Vinci surgical system that brought significance and innovation in the MIS domain. Being one of the pioneers in the MIS market, the establishment is equipped with progressive sales team and R&D. Novel innovations, mostly surgical robots, are likely to boost the demand for the market

The key players are capitalizing in R&D activities in order to boost the lucrative market. Furthermore, some of them are choosing for the acquisition of smaller companies to strengthen and expand their local outreach.  

Stryker; Medtronic; Abbott; Smith & Nephew; NuVasive, Inc.; Zimmer Biomet; Intuitive Surgical, Inc; and CONMED are some of the leading players in the minimally invasive surgical instruments market. 

Internet of Things (IoT) in Healthcare- Trend of Remote Patient Monitoring

The key focus area of Internet of Things (IoT) is to add new internet sharing devices in information and communication technology. It works by merging short-range mobile transceivers into devices such as 3D printed organs, camera pills, predictive assistance devices, and fridge controller. This technology is mainly used in biotechnology, hospitals, pharmaceutical companies, and diagnostic laboratories to use their resources more competently.

Hospitals and Clinics End-User Segment to Spur Demand

The end user variants of market include research and diagnostic laboratories, hospitals and clinics, clinical research organizations, and others. Hospitals and clinics segment account for the major share and are anticipated to maintain their dominance in the forecast period. Improved operational and functional effectiveness by hospitals owing to IoT is a significant factor for its wide-ranging usage. IoT solutions allow enhanced patient experience, treatment outcomes, and disease management leading to improved care delivery. 

Furthermore, these solutions also support hospitals in the organization of billing, inventory, and medical records, medication compliance, hospital workflows, and real-time communication improving the complete operative effectiveness.

Hospitals are investing a lot to gain the acceptance of digital technology and are accountable for its major share in the market. Inclination toward value-based care in the established economies is also expected to boost the acceptance of IoT solutions in hospitals in the years to come. 

Clinical Research Organizations (CROs) sector is anticipated to register the highest CAGR over the forecast period. Rising acceptance of IoT solutions for improving the efficiency of clinical research is a significant factor propelling the segment. 

CROs use these solutions extensively for developing patient retention and recruitment process, which are the possible problems in medical research. This is projected to drive the segment growth in the years to come.

Market Insights:

Leading players operating in the internet of things (IoT) in healthcare market include Koninklijke Philips N.V.; Microsoft Corp.; Cerner Corp; IBM Corp.; and Cisco Systems, Inc.In 2016, IBM cooperated with Pfizer for advancing a system to progress clinical research procedure for Parkinson’s disease. Such collaborations with other industry contributors, investments in R&D, and service variation are the significant marketing policies accepted by these establishments.

Self-Retaining Retractors- A Minimally Invasive Surgical Tool

7th May 2019: A surgical instrument is a particularly designed device or tool utilized during a surgery to provide access for viewing or modifying biological tissue. Forceps, scalpels, retractors, and scissors are among a wide array of hand-held surgical instruments used in numerous medical procedures. These tools are typically made of high-grade stainless steel and exist in a wide variety of designs, shapes, and sizes. 

Diverse Use of Retractors in Surgical Procedures to Boost Market

The major product-variants of hand-held surgical instruments include retractors, forceps, dilators, scalpels, graspers, etc. The others segment comprises cannulas, clamps, closure devices, bone saw, bone chisel, curette, dissecting knife, scalpel, dermatome, osteotome, trocars, rongeur, and surgical elevator. The segment dominated the market in 2017 due to diverse use of these instruments in several operating methods.

Retractors surpassed the market due to technological innovations in product development, for example, use of self-retaining retractors in hands-free surgery. These retractors exist with opposable blades that use a screw or clamp to hold the tissues apart by themselves.

Retractors segment is followed by the forceps segment and is anticipated to maintain its dominance till 2025. Forceps help to hold minute objects that cannot be grabbed with hands or fingers such as in dental procedures. Based on the requirement, several types of forceps are used during surgeries: hemostats, dressing, splinter, needle holders, sponge, obstetric, towel, tubing, and tissue forceps.

A high number of operating processes are performed across the globe every year. In 2015, as per the OMICS International Conferences, around 234 million surgical processes were being performed every year. This is another factor expected to drive the market in the years to come.

Market Insights:

The Hand-held Surgical Instruments market is expected to face strong competition throughout the forthcoming period due to the existence of multinational establishments. Novel product development, joint ventures, and geographical expansion are some of the important policies accepted by significant market players.

Leading players operating in the hand-held surgical instruments market include B. Braun Melsungen AG; Zimmer Biomet Holdings; Becton, Dickinson and Company; Integra Smith & Nephew; Life Sciences Corporation; Johnson & Johnson; Medtronic; Cooper Surgical Inc.; Aspen Surgical; and Thompson Surgical Instruments Inc.

Brachytherapy to Emerge as Preferred Treatment for Prostate Cancer

16th April 2019: There have been different ways of treating cancer, such as surgery, internal and external radiation therapies, etc. Brachytherapy also known as internal radiation, helps doctors deliver a high or low dosage of radioactive drugs to specific body parts for treating cancer cells.  Product innovations, R&D initiatives, and technological advancements are fueling the popularity of the market.

HDR; An Advanced Tech for Treating Prostate Cancer 

Modern society has witnessed technology in action when it comes to the healthcare industry. One in seven men are diagnosed with cancer in their lifetime and the good news is that more people are surviving owing to improving treatments. Brachytherapy has altered cancer therapy standards and is enhancing the chances of optimal patient outcomes. High-dose-rate (HDR) can deliver concentrated radiation bursts for a short amount of time. This procedure has registered better tolerance with fewer side effects. HDR has found its widespread application in treating prostate cancer and is anticipated to bode well during the upcoming years. 

A Seed of Hope

The high-dose-rate techniques deliver seeds or pallets of radioactive drugs contained in an afterload device, placing it directly at the tumor site for a brief period of time. This is minimally invasive and eliminates any side effects by sparing the surrounding healthy tissues. HDR has been gaining traction over the past few years as a less harsh alternative to conventional radiation therapy. In March 2018, the Journal of the American Medical Association (JAMA) revealed that mortality rate due to prostate cancer dropped to 3 percent (versus 12 and 13 percent, when treated with external beam radiotherapy (EBRT) alone). This fact can be attributed to the gauging effectiveness of combining EBRT and brachytherapy. IsoRay introduced HDR cesium (Cs)-131 with superior real-time clinical outcomes. 

Market Insights:

Internal radiation therapy has proven to be very effective in treating cancer, as it has a minimal risk of side effects. This can be owed to of its nature of targeted drug delivery an on-point treatment mechanism from inside the body. According to the World Health Organization, more than 2 million women are affected by breast cancer and the number is rising each year. Presence of a favorable regulatory scenario and several acquisition activities are playing a pivotal role in market’s further expansion. iCAD, Inc., in February 2019 announced their collaboration with the Karolinska Institutet to implement iCAD’s AI cancer detection software to assess an individual’s risk of inflicting or developing breast cancer.

The competitive landscape showcases the profiles and business strategies of the major players, along with their recent developments. The brachytherapy market is highly fragmented with a presence of several key players like GE Healthcare, IsoRay Medical, Inc., Eckert & Ziegler BEBIG, Carl Zeiss Meditec AG, Panacea Medical Technologies, Argon Medical Devices Inc., Boston Scientific Corporation, Elekta AB, CR Bard Inc., and Varian Medical Systems, Inc., among others. Growing investments in medical research are providing lucrative opportunities for industry players in North America. Asia Pacific is the fastest growing region owing to the rising number of geriatric populations, disposable income, and surging pool of medical practitioners.

Hair Removal Devices for Effective and Painless Results

13th March 2019: Hair removal devices are being extensively used for removing hairs due to their efficiency and effectiveness. These devices are also preferred owing to increasing popularity of non-invasive techniques for personal grooming. Several alternative techniques such as manual trimming, waxing, and use of razors are comparatively painful, also results in irritation of skin. Additionally, these methods offer temporary results and require repeating same task after some days. However, use of advanced hair removal devices benefits user to reduce repetitive treatment effort for months or years.

These devices are developed for home use, beauty clinics, and dermatology clinics.

Introduction of Advanced Products can Support Growth 

The hair removal products can be categorized into laser, intense pulse light, and other energy-based devices. The laser segment estimated for the largest share in 2017 on account of its quick results. They are considered harmless, causes less pain, and suitable for all skin tones. The segment is likely to grow on account of increasing technological developments. For example, new equipment emit longer wavelengths of light provides greater focus on the melanin present in hair follicles, which reduces the skin burns. The laser devices can be further classified into diode laser, Nd: YAG laser, and alexandrite laser. The U.S. has been one of the largest users of these devices. For instance, Lumenis Ltd., has recently launched a SPLENDOR X, the solid-state laser system. It is equipped with BLEND X technology that enables fast and effective hair removal. It is suitable for all skin types including dark and tanned skin. In addition, it’s a built-in plume evacuator claim to make a smoke free and safer environment.

On other hand, in 2017, the intense pulse light devices captured prominent revenue share in 2017 owing to their demand for home-use. These devices are supposed to be convenient for home users but less effective than lase devices. As, these devices generates light at multiple wavelengths, which scatter through skin.

Market Overview

According to a report published by Grand View Research, Inc.; the global hair removal devices market is anticipated to reach a valuation of around USD 3.4 billion by 2025. Growing awareness among consumers about physical grooming and need for improving aesthetic appeal can impel the market during the forecast period (2014 to 2025). Increasing consumers spending capacity is also expected to support the market growth. Increasing use of these devices among male consumers is also expected to support the market growth.

In 2017, North America dominated the market due to availability of technologically advanced products and high awareness about physical grooming. Europe is expected to display significant growth on account of presence of skilled dermatologist. Asia Pacific is projected to expand due to growing beauty consciousness in emerging countries.

Key vendors operating in the hair removal devices market include Cynosure, Inc.; Sciton, Inc.; Lutronic; Alma Lasers; and Venus Concept Canada Corp.

Chemical-free Feminine Hygiene Products to Ensure Safety

Thursday, 28 February 2019: Feminine hygiene products are essential for women to maintain personal hygiene during vaginal discharge, menstruation, and other physical functions. These products can be also used by transgender men, and genderqueer (non-binary) population.

These products can be available across several distribution channels such as pharmacies, online retail stores, and supermarkets. Many consumers purchase products from pharmacies or supermarkets. However, development of several e-commerce platforms for buying these products are also becoming popular among working women population.

Rising Cognizance to Drive the Growth

Feminine hygiene products can be categorized into menstrual care, and cleaning and deodorizing. The menstrual care products segment comprises sanitary napkins, menstrual cups, and tampons. The segment is expected to continue to lead in terms of revenue in the coming years due to their repetitive and easy use. These products are basic requirement of women between age group twelve to forty-five. The sanitary napkins estimated for the prominent share in terms of revenue as they are preferred by women across the world and all age groups as they are available in different sizes. They offer better comfort and easy to use as compared to tampons. The use of tampon has been observed in western countries due to high awareness about women sanitization and hygiene as compared to developing countries. In addition, taboo related to menstrual hygiene is also considered as another reason for limited use of tampons in emerging regions.

Moreover, the practice of menstrual cups is likely to grow in the year to come with rising awareness. The cups are comparatively cheap and can be reused. These products are made up with silicon, which are environment friendly and chemical free. Thus, demand for these products are expected to rise with awareness. For instance, Tampax has recently launched a new product called Tampax Cup, a menstrual cup that can be suitable for all body types to provide comfort and protection of up to 12 hours. It is manufactured using 100% medical grade silicon and design with SoftCurve shape.

Cleaning and deodorizing products include feminine powders, soaps, feminine wipes, internal cleaners, sprays shields, and many other products. Feminine soaps, powders, and internal washes are used to take care of vaginal health as well as maintaining healthy pH at vaginal area. This is expected to boost their usage.

Market Overview

According to a report published by Grand View Research, Inc.; the global feminine hygiene products market is anticipated to reach a valuation of around USD 33.78 billion by 2025. Growing awareness about benefits of these products coupled with increasing disposable income in emerging countries can impel the market growth over the forecast period (2014 to 2025). Additionally, increasing efforts to spread awareness about these products by government and manufactures can drive the market growth over the forecast period. Increasing efforts towards the development of easy to use and environment friendly products are also expected to boost the market growth.

Some of the leading companies operating in the feminine hygiene products market include Edgewell Personal Care, Lil-Lets UK Ltd., Unicharm Corporation, Kao Corporation, and Unicharm Corporation.

Amniotic Membrane: Regenerative Treatment for Healthier Patient Outcome

Tuesday, 26 February 2019: Amnion or amniotic membrane is the innermost layer of the placenta. It comprises an avascular stromal matrix and thick basement membrane. Its transplantation has been used as a graft in many surgical procedures. It consists of pain reduction, anti-inflammatory, and wound healing properties.

Amniotic membrane contains growth factors such as basic fibroblast growth factor (bFGF), epidermal growth Factor (EGF), transforming growth factors (TGFs), vascular endothelial growth factor (VEGF), keratinocyte growth factor (KGF), and nerve growth factor (NGF), which aid in wound healing. These products are being widely used in the management of chronic wounds, treatment of venous, surgeries, ophthalmology, pressure, and diabetic foot ulcers.

Utilization in Reconstructive Surgeries can Boost Demand 

Amniotic membrane finds applications in surgical wounds, ophthalmology, and others. These products are increasingly used in ophthalmic surgeries for quick recovery and reducing inflammation. It is preserved in cryopreserved amniotic membranes with its biological and histological properties. So, these products are being increasingly used in ocular surgeries for faster recovery and reduced inflammation of the eye. For instance, BioStem Life Sciences has recently introduced placental-derived tissue products for orthopedic ophthalmology, and advanced wound care. They are named such as a chorion-free amniotic tissue allograft membrane, an amniotic tissue allograft flowable matrix, and an extracellular amniotic membrane allograft for ocular repair, an amniotic tissue allograft membrane with chorion layer.

The amnion is utilized in reconstructive surgeries to reduce scarring and boost healing. High demand for cosmetic surgeries is expected to drive the segment growth in the coming years. As per information provided by American Society of Plastic Surgeons, in 2017, more than 17.5 million surgical cosmetic procedures were achieved in the U.S. This also concludes that number of surgeries for improving astatic appeal has increased.

Dehydrated amniotic membranes, such as FlōGraft, AmnioFix, PalinGen, and AmbioDisk, are preferred in reconstruction surgeries, and to treat surgical wounds, and venous and pressure leg ulcers. Utilization of these products in burn injury treatments provide epithelialization, which is an essential component for wound healing. It also enables relaxed movements of the injured area. These products are inexpensive as compared to allografts and xenografts. This is also expected to drive the segment growth.

Market Overview

According to a report published by Grand View Research, Inc.; the global amniotic membrane market is expected to accomplish a valuation of around USD 5.81 billion by 2025. Growing R&D efforts related to stem cells and regenerative medicines and growing number of surgical procedures all over the world due to burn cases and accidents can propel the market during the forecast period (2014 to 2025). Growing awareness about these products has increased the number of transplants, which requires tissue-based products. This has also increased the number of placental donations, thereby driving the market growth.

North America was estimated as largest markets in 2017. In terms of revenue, Europe was the second leading markets in the same year and expected to expand at a CAGR of 11.9% during the forecast period. This can be ascribed to high occurrence of chronic diseases and surgical procedures. Asia Pacific is also expected to exhibit high CAGR on account of improving economic condition and increasing efforts for medical research. Numerous international companies are also investing heavily in the region.

Key companies operating in the amniotic membrane market include MiMedx Group, Inc.; Human Regenerative Technologies; Skye Biologics, Inc.; Organogensis, Inc. and Amniox Medical, Inc.

Innovative Portable Devices to Expand Anesthesia and Respiratory Devices Market

5 October 2018: According to a report by Grand View Research, Inc., the worldwide anesthesia and respiratory devices market is likely to reach USD 26.8 billion by 2022. Anesthesia and respiratory devices are widely used during almost all surgeries and treating respiratory diseases.

On September 17, 2017, Masimo received FDA 510(k) clearance for new product Rad-97 pulse co-oximeter and introduced the device in the US.  The product comprises noninvasive blood pressure monitoring technology, continuous monitoring and SET pulse oximetry, and NomoLine capnography. It also encompasses a small footprint and easy configuration, a multi-touch dispaly, Masimo touted, with built-in enterprise Bluetooth and WiFi support to connect compatible devices such as weight scales, glucometers, and thermometers. It can be used in many healthcare environments like alternate care, lower-acuity settings in hospitals, telehealth, and other.

Royal Philips launched its new and small positive airway pressure (PAP) device named DreamStation Go. This device can be beneficial for patients suffering from obstructive sleep apnea (OSA). The device is developed to complete travelling patient’s requirements. The product is available in auto-titrated APAP model as well as fixed-pressure continuous positive airway pressure (CPAP). Both models are facilitated with Bluetooth and can be linked with Philips’ EncoreAnywhere, which can help user to monitor therapy performance across several devices from one shared dashboard. It can be also united with care Orchestrator cloud-based patient management systems for clinicians.

Factors such as growing elderly population, increasing occurrence respiratory complaints including obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD), and increasing environmental pollution can propel anesthesia and respiratory devices market during the forecast period (2012 to 2022).

However, high costs of these devices and availability of alternate medications may restrict the market growth during the forecast period.

North America has been dominating the market due to availability of the developed healthcare infrastructure and high awareness among the people.

Some of the leading players operating in the market include Draegerwerk AG, GE Healthcare, Smith Medicals, Philips Healthcare, and Fisher and Paykel.

Read more @ 
https://www.grandviewresearch.com/industry-analysis/anesthesia-and-respiratory-devices-market

Surgical Drainage Devices to Reduce Surgery Cost and Time

26 September 2018: Rising number of chronic infections and growing adoption of surgical treatments to avail instant relief are anticipated to exhilarate demand for surgical drainage devices. Such devices are necessary to prevent accumulation of fluids such as infected fluids, pus, and blood surgical treatments.    

Handheld Device CLiKX to Treat Blue Ear Effectively

Major products variants of surgical drainage devices are active and passive devices. The active devices are likely to be dominating and generate maximum revenue in the coming years. Such devices can evacuate fluid to prevent buildup during surgeries. The evacuation is mostly processed through vacuum or wall suction. Surgeons performing particular surgery can select active drainage device according to the type of surgery. Increasing number of surgical procedures are predicted to impel demand for advanced surgical drainage devices.

Considering the rising demand, most researchers and manufacturing companies involved are focusing on R&D investments to discover new and innovative devices. For instance, a group of researchers from the national university of Singapore (NUS) recently developed CLiKX, a novel handheld device to treat otitis media with effusion (OME). In case of OME, non-infected fluid gets collected in the middle ear space due to cold, respiratory infection, and sore throat. 

Market Insights

The worldwide surgical drainage devices market is predicted to reach USD 2.3 billion by 2025, according to a report by Grand View Research, Inc. Increasing number of surgeries owing to rising cases of chronic diseases is one of the major factors likely to drive growth of the market. Growing demand for surgical drainage devices during and post surgeries to prevent fluid accumulation can augment market growth. Technological advancements in medical infrastructure coupled with proper integration of ambulatory health services is expected to stimulate growth of the market. Growing use of such devices in minimally invasive medical procedures can fuel market growth during the forecast period 2017 to 2025.

Some of the prominent players operating in the market for surgical drainage devices are Medtronic; Acelity; Cardinal Health; Teleflex Incorporated; and Cook Medical.

Read more @ 

https://www.grandviewresearch.com/industry-analysis/surgical-drainage-devices-market